The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism

Abstract Male germ cell tumors (GCT) have excellent survival. Long-term sequelae in cancer survivors are an evolving field. We evaluated the risk of patients with GCT to develop primary hypogonadism and adherence to guideline-recommended therapy in a real-world cohort. Monocentric study at a tertiar...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Analena Handke, Marla Geller-von Bargen, Aykhan Isgandarov, Mulham al Nader, Ulrich Krafft, Christopher Darr, Boris Hadaschik, Viktor Grünwald, Lukas Püllen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Nature Portfolio 2024-11-01
Sarja:	Scientific Reports
Aiheet:	Germ cell tumor Secondary hypogonadism
Linkit:	https://doi.org/10.1038/s41598-024-78765-w
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!